CD7 is a transmembrane glycoprotein ubiquitously expressed on most T cells and NK cells and is particularly highly expressed in T-ALL and some PTCL subtypes, making it a key target for immunotherapy for T-cell malignancies. This evidence concerns the gene CD7 and mature T-cell and NK-cell non-Hodgkin lymphoma.